Compare PCVX & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCVX | CHRD |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.1B |
| IPO Year | 2020 | 2010 |
| Metric | PCVX | CHRD |
|---|---|---|
| Price | $46.76 | $97.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $101.67 | ★ $132.64 |
| AVG Volume (30 Days) | ★ 1.5M | 709.7K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 5.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.96 |
| Revenue | N/A | ★ $4,850,258,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $33.02 |
| Revenue Growth | N/A | ★ 9.04 |
| 52 Week Low | $27.66 | $79.83 |
| 52 Week High | $94.60 | $129.32 |
| Indicator | PCVX | CHRD |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 61.90 |
| Support Level | $43.78 | $92.10 |
| Resistance Level | $48.11 | $95.43 |
| Average True Range (ATR) | 1.99 | 2.77 |
| MACD | -0.49 | 0.83 |
| Stochastic Oscillator | 42.99 | 81.19 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.